Retatrutide
A synthetic triple-agonist peptide with reported affinity for the GLP-1, GIP and glucagon receptors, supplied as a lyophilised reference material for laboratory research into metabolic receptor signalling.
Compound Overview
Retatrutide is a synthetic polypeptide investigated in the scientific literature as a single molecule with reported agonist activity at three distinct receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. This triple-receptor profile is what distinguishes it from single- and dual-agonist peptides in the same research area.
Research Background
Published research involving retatrutide sits within the broader field of incretin and metabolic receptor pharmacology — a literature concerned with how receptor signalling contributes to the regulation of glucose handling and energy balance in model systems. Retatrutide appears in that literature as an investigational compound of interest for studying simultaneous multi-receptor engagement.
The information above is provided solely to identify what this compound is and the areas of scientific literature in which it appears. It is not a representation of effect, benefit or outcome, and is not an invitation or recommendation to use this compound in any living subject.
Areas Of Research Interest
- Incretin receptor pharmacology
- GLP-1 / GIP / glucagon receptor signalling
- Metabolic pathway research
- Comparative multi-agonist studies
Specifications
| Presentation | Lyophilised powder in sealed vial |
|---|---|
| Quantity | 30mg |
| CAS number | 2381089-83-2 |
| Molecular weight | ≈4731 g/mol |
| Purity testing | Third-party tested for purity and identity; COA available on request |
| Storage | Store sealed, refrigerated and protected from light. Handling and storage are the responsibility of the purchaser. |
| Intended use | Laboratory research use only — not for human or veterinary consumption |
Analysis & Certificates
Every batch is submitted for independent third-party analysis to verify purity and identity. The certificate of analysis relates only to the specific batch tested, and speaks only to the purity and identity of that batch. A certificate of analysis is not an indication of safety, suitability or fitness for any purpose, and does not imply approval for use in humans or animals.
🔬 View published lab report — Batch RE30-0208
To request the COA for your batch, message us on WhatsApp with the batch number printed on the vial.
Questions
Retatrutide is a synthetic polypeptide investigated in the scientific literature as a single molecule with reported agonist activity at three distinct receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. This triple-receptor profile is what distinguishes it from single- and dual-agonist peptides in the same research area.
No. Retatrutide is not a licensed medicinal product and holds no marketing authorisation from the MHRA or any other regulatory body. It has not been evaluated for safety or efficacy in humans. It is supplied strictly as a reference material for laboratory research use only, and must not be administered to any human or animal.
Yes. Every batch is submitted for independent third-party analysis to verify purity and identity. The certificate of analysis for the batch you receive is available on request — message us with your batch number and we will send it over.
No. We do not supply dosing information, administration protocols or usage guidance of any kind, for any compound, under any circumstances. Enquiries seeking such information will not be answered and may result in an order being cancelled and refunded.
Lyophilised compounds are supplied as a dry powder for stability and require a solvent before use in any solution-phase research application. Bacteriostatic water is the standard laboratory solvent for this purpose.
We currently ship within the United Kingdom only. Orders placed before 2pm GMT on a working day are normally dispatched the same day, in plain unbranded packaging with tracking. Purchasers are responsible for ensuring possession and use of these materials is lawful in their jurisdiction.
Omni Peptides supplies retatrutide (30mg) in the UK as a research-grade reference material, dispatched from our base in Stafford with tracking. Every batch is third-party tested for purity and identity, and a certificate of analysis is available. It is supplied strictly for laboratory research use only.
Yes. Omni Peptides is a UK-based supplier of research-grade retatrutide, shipping across the United Kingdom from Stafford. Orders are third-party tested with a certificate of analysis available, dispatched in plain, unbranded packaging with tracking.
Retatrutide is £119.99 per 30mg vial, supplied as a third-party tested research-grade reference material for laboratory research use only.
Further Reading & Guides
Related Research Compounds
Important: This product is supplied strictly as a reference material for laboratory research use. It is not for human or veterinary consumption. Do not purchase it if you intend to administer it to yourself, any other person, or any animal. Read our full Research Use Disclaimer.